Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.3 - $6.29 $83,950 - $229,585
-36,500 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.63 - $9.94 $1.45 Million - $3.11 Million
-312,610 Reduced 89.54%
36,500 $209,000
Q4 2021

Feb 11, 2022

BUY
$8.35 - $12.6 $2.92 Million - $4.4 Million
349,110 New
349,110 $3.19 Million
Q2 2021

Aug 16, 2021

SELL
$13.27 - $18.48 $490,990 - $683,760
-37,000 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$14.49 - $20.72 $657,846 - $940,688
-45,400 Reduced 55.1%
37,000 $600,000
Q1 2020

May 15, 2020

BUY
$10.23 - $24.56 $842,952 - $2.02 Million
82,400 New
82,400 $967,000
Q4 2019

Feb 13, 2020

SELL
$17.42 - $26.61 $1.37 Million - $2.09 Million
-78,650 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$16.36 - $21.39 $877,714 - $1.15 Million
53,650 Added 214.6%
78,650 $1.46 Million
Q2 2019

Aug 13, 2019

SELL
$16.93 - $26.22 $206,546 - $319,884
-12,200 Reduced 32.8%
25,000 $465,000
Q1 2019

May 14, 2019

BUY
$23.15 - $28.34 $861,180 - $1.05 Million
37,200 New
37,200 $909,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $190M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.